Evidence map›Paper›PMID 40201557›Full record

ArticleIJID regions2025

Inequities underlie the alarming resurgence of Tuberculosis as the world's top cause of death from an Infectious Disease - Breaking the silence and addressing the underlying root causes.

Alimuddin Zumla, Suvanand Sahu, Lucica Ditiu, Urvasha Singh, Young-Joon Park, Dorothy Yeboah-Manu, Stephen Osei-Wusu, Danny Asogun, Peter Nyasulu, John Tembo and 10 more

Abstract readEditorial
In one paragraph

Article in IJID regions, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Alimuddin ZumlaDepartment of Infection, Centre for Clinical Microbiology, Division of Infection and Immunity, University College London, London, United Kingdom; NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, United Kingdom.
Suvanand SahuStop TB Partnership Secretariat, Global Health Campus, Geneva, Switzerland.
Lucica DitiuStop TB Partnership Secretariat, Global Health Campus, Geneva, Switzerland.
Urvasha SinghCentral TB Division, Ministry of Health & Family Welfare, New Delhi, India.
Young-Joon ParkDepartment of Infectious Disease Policy, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea.
Dorothy Yeboah-ManuDepartment of Bacteriology, Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana.
Stephen Osei-WusuDepartment of Bacteriology, Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana.
Danny AsogunIrrua Specialist Teaching Hospital, Irrua, Nigeria.
Peter NyasuluDivision of Epidemiology and Biostatistics, School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
John TemboHerpeZ, and UNZA-UCLMS Programs, University Teaching Hospital, Lusaka, Zambia.
Nathan KapataDepartment of Medicine, Apex University School of Medicine, Lusaka, Zambia.
Fatma AlyaqoubiThe Centre for Diseases Control and Prevention, Ministry of Health, Muscat, Oman.
Amal Al MaaniThe Centre for Diseases Control and Prevention, Ministry of Health, Muscat, Oman.
Lucille BlumbergNational Institute for Communicable Diseases, Division of the National Health Laboratory Service, Johannesburg, South Africa and Right to Care; University of Pretoria, Faculty of Veterinary Science, South Africa.
Adam ZumlaRoyal Bolton Hospital, Respiratory Department, Bolton NHS Foundation NHSTrust, Bolton, and Institute of Medicine, University of Greater Manchester, UK.
Rizwan AhmedRoyal Bolton Hospital, Respiratory Department, Bolton NHS Foundation NHSTrust, Bolton, and Institute of Medicine, University of Greater Manchester, UK.
Unyeong GoCenter for Infectious Diseases, Green Cross Laboratories, Yongin, Republic of Korea.
David S HuiDepartment of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.
Delia GolettiTranslational Research Unit, National Institute for Infectious Diseases "Lazzaro Spallanzani"- Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy.
Eskild PetersenDepartment of Science and Environment, PandemiXcenter, Roskilde University, Roskilde, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

•The WHO End TB strategy is stalling as shown in the Global Tuberculosis Report 2023.•The main reason is unequal access to tuberculosis diagnosis and treatment.•Tuberculosis diagnosis and treatment must be expanded outside urban centers down to the smallest and most remote unit.•Screening risk populations for latent tuberculosis will help identify infected persons before they develop active tuberculosis.

Identifiers

PMID40201557
PMCPMC11973691

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.